Taxonomy3® is used to analyse complex genetic datasets to identify and characterise novel drug target candidates. Since these novel targets are based on human genetic data, the resulting drugs have a greater probability of successful clinical development and product realisation. By performing highly sensitive in silico mining and analysis of publicly available DNA databases, Taxonomy3® is able to identify previously unknown genetic linkages and interactions between genes and biological pathways in a broad range of diseases. This enables the discovery of targets that cause disease, rather than those that are simply associated with its symptoms, and thereby provides the best starting point for drug discovery, biomarker identification and patient stratification, and ultimately improving the chances of clinical success.

Home page of this offering   provided by C4X Discovery